Kimberly Guilfoyle resigns as U.S. ambassador to Greece amid misconduct allegations
03:06
Katie Zacharia holds first White House press briefing weeks before midterm elections
03:17
Rep. Omar Reacts to Feds' Home Search: 'I Will Not Be Silenced'
02:17
Trump Campaigns in Ohio as Democrats Look to Flip Seat
06:17
ICE officers hit man running from them with SUV
01:29
Hunger deepens in a rural community hit by Trump’s cuts
05:04
Brad Raffensperger defends election security in Georgia ahead of consequential midterms
04:25
Trump faces ‘bipartisan pushback’ on diesel deal with Russia as he tries to lower prices
17:37
‘I’m asking for proof of spine from him’: Talarico challenges Paxton to debate
04:58
Texas Republicans at odds over GOP Senate nominee Ken Paxton
02:37
Federal agents search Rep. Ilhan Omar's home in ongoing criminal probe
03:00
Kerry Kennedy Talks New Book Honoring Mother Ethel’s Legacy
07:57
Federal Judge Orders Trump to Stop Airing Ads Paid for by Taxpayers
00:57
Trump Faces Intense Bipartisan Backlash Over Russian Oil Deal
03:26
Post Game: Obama campaigns for Abdul El-Sayed despite his past criticism
14:06
Thom Tillis says ‘I made a mistake’ confirming Pete Hegseth
02:26
Abdul El-Sayed Responds to Mike Rogers’ Claims of Terrorist Ties
01:56
Trump Says Ukraine Needs a New Leader After Zelenskyy Clash
01:46
Abdul El-Sayed addresses past criticism of Obama: 'I was younger’ and ‘angry’
14:12
Abdul El-Sayed says Democrats must win midterms by 'massive numbers': Full interview
32:33
Top Story
Eli Lilly CEO talks deal to cut medication prices with the Trump administration
Catch up with NBC News Clone on today's hot topic: Eli Lilly Ceo Talks Deal To Cut Medication Prices With The Trump Administration 251511365505 - Breaking News | NBC News Clone. Our editorial team reformatted this story for clarity and speed.
09:10
Copied
NBC News' Tom Llamas talks to CEO of Eli Lilly David Ricks about the company's new deal with the Trump administration to cut down some of the cost of their weight loss drug Zepbound. Nov. 7, 2025
